ClinConnect ClinConnect Logo
Search / Trial NCT05594888

GRIP: Maximum Isometric Grip Strength Assessed with Three Different Hand-held Dynamometers

Launched by JOHANNES SCHERR · Oct 24, 2022

Trial Information

Current as of May 14, 2025

Completed

Keywords

Maximum Isometric Grip Strength Hand Held Dynamometer Reference Values Physical Therapy

ClinConnect Summary

The GRIP clinical trial is studying how to measure grip strength using three different devices to find out which one works best. Grip strength is an important way to assess upper body strength in both adults and children, and the current standard device is called the JAMAR Hydraulic Hand Dynamometer. However, this trial aims to compare this standard device with two other devices—the JAMAR Smart Hand Dynamometer and the Martin Vigorimeter—to see if they are just as reliable and accurate. The researchers also want to gather reference values for grip strength based on different age groups, genders, and activity levels.

To participate in the trial, volunteers should be between 10 and 64 years old and have a healthy body weight (a BMI less than 30). If a participant is under 14, a parent or guardian must give consent. However, individuals with certain injuries, diseases affecting their arm strength, or cognitive impairments are not eligible to join. Participants in this trial can expect to engage in simple grip strength tests and help researchers gather valuable information that could improve how grip strength is measured in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria Part 1:
  • Male and female volunteers with age 18-64 years
  • Body mass index \< 30 kg/m2
  • Informed consent signed
  • Inclusion Criteria Part 2:
  • Male and female volunteers with age ≥ 10 years
  • Informed consent signed (if age \< 14 years, signed by parents or legal guardians)
  • Exclusion Criteria Part 1 and 2:
  • Disease or injury (e.g., musculoskeletal or neurological) that could affect upper extremity strength
  • Physical impairment of the upper extremity (visible swelling or the presence of a splint or cast)
  • Acute pain or infection
  • Cognitive impairment (inability to understand and/or follow directions)
  • Insufficient language of the German language

About Johannes Scherr

Johannes Scherr is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and treatment strategies, Scherr collaborates with healthcare professionals and research institutions to facilitate the development and execution of clinical trials. Emphasizing rigorous scientific standards and ethical practices, the organization aims to enhance the understanding of diseases and contribute to the discovery of effective solutions that address unmet medical needs. Through strategic partnerships and a patient-centered approach, Johannes Scherr is poised to make significant contributions to the field of clinical research.

Locations

Zürich, , Switzerland

Patients applied

AK

1 patients applied

Trial Officials

Johannes Scherr, Prof Dr med

Principal Investigator

Balgrist University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials